Changfei Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 4
-
- Hepatitis C virus research 5
Changfei Li
37 papers receiving 867 citations
Peers
Comparison fields: 5 of 113
- Cancer Research 387
- Hepatology 153
- Molecular Biology 521
- Epidemiology 241
- Immunology 133
Countries citing papers authored by Changfei Li
This map shows the geographic impact of Changfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changfei Li more than expected).
Fields of papers citing papers by Changfei Li
This network shows the impact of papers produced by Changfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changfei Li. The network helps show where Changfei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changfei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 10 | |
| 5 | 2020 | 12 | |
| 6 | 2020 | 16 | |
| 7 | 2018 | 29 | |
| 8 | 2017 | 68 | |
| 9 | 2017 | 8 | |
| 10 | 2016 | 16 | |
| 11 | 2016 | 19 | |
| 12 | 2015 | 23 | |
| 13 | 2015 | 26 | |
| 14 | 2014 | 29 | |
| 15 | 2014 | 17 | |
| 16 | 2013 | 21 | |
| 17 | 2012 | 172 | |
| 18 | 2012 | 21 | |
| 19 | 2010 | 25 | |
| 20 | 2008 | 17 |
About Changfei Li
Changfei Li is a scholar working on Cancer Research, Hepatology, Epidemiology, Immunology and Immunology and Allergy, having authored 38 papers that have together received 876 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (12 papers), MicroRNA in disease regulation (11 papers), RNA Interference and Gene Delivery (7 papers), Heat shock proteins research (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Hepatitis C virus research (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (387 citations), Hepatology (153 citations), Molecular Biology (521 citations), Epidemiology (241 citations) and Immunology (133 citations). Changfei Li has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Songdong Meng, Junli Hao, Jun Hu, Saifeng Wang, Lizhao Chen, Yaxing Xu, Ying Ju, Hongxia Fan, Xin Ye and Bo Wu. Their work appears in journals such as Scientific Reports, Vaccine, Cancer Letters, Oncotarget and Protein & Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.